Top Biotech ETF 看多

Range Cancer Therapeutics ETFNASDAQ

描述

⋅ 2018年3月6日早上2點58分

This is CNCR Loncar Cancer Immunotherapy ETF, it is trading +25% year to date, some of its 30 holdings are ATRA, IOVA, NKTR, JNCE, BGNE, ACEN, 64% in Micro Cap, last price $30.60, expense ratio 0.79%. We are bullish on it and you could too.